MAURIZIO VECCHIONE

Maurizio is the Executive Vice President for Global Good and Research at Intellectual Ventures (IV). He oversees their collaboration with Bill Gates to invent and deploy technology specifically focused on improving life in developing countries, as well as the research and operations of the IV Laboratory and Institute for Disease Modeling. Maurizio most recently served as CEO of Arrogene, which is commercializing a new nanotechnology platform for cancer targeted therapeutics and diagnostics, and as CEO of telemedicine pioneer CompuMed.

Under Maurizio’s leadership, Global Good and the IV Lab are engaged in cutting-edge research and invention for the benefit of humanity around global health and global development priorities. In global health, they are involved in new diagnostic technologies for infectious diseases, enhanced vaccine delivery technologies, maternal and child health, as well as IV’s Institute for Disease Modeling efforts to shape infectious disease policy and programs with data- driven analysis. In global development, Global Good and IV Lab focus their work on malnutrition, agricultural productivity, livestock and dairy value chain improvements for the developing world, with a particular emphasis on the needs of smallholder farmers.

Maurizio has nearly 30 years of experience in research and the technology sector. He has contributed to building nine start-ups and helped launch more than 50 commercial products, resulting in more than $1 Billion in shareholder value. His work spans the software, Internet, wireless and life sciences sectors, primarily in connection with translational sciences for science derived from government and academic R&D efforts.

Maurizio is also involved in a number of non-profit initiatives, including ReefQuest, for which he is a co-founder and member of the board. This global organization focuses on fostering marine environmental stewardship in children through citizen science.As an inventor himself, Maurizio is named on multiple U.S. patents and patent applications related to imaging, image processing, nano-bio-polymer and telecommunications technologies. He was twice a finalist for the E&Y Entrepreneur of the Year award, received a DEMO God award from the prestigious DEMO organization and is a member of AAAS, ACM and IEEE.

Evan Wei-Haas